Cancer drugs kill tumor cells. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy17

Cell Line, Tumor Tumor Cells, Cultured Killer Cells, Natural T-Lymphocytes, Cytotoxic Cell Line Neoplastic Cells, Circulating Macrophages Neoplastic Stem Cells Cells, Cultured HCT116 Cells HT29 Cells Breast Lymphocytes, Tumor-Infiltrating Lymph Nodes Fibroblasts T-Lymphocytes Epithelial Cells

Organisms6

Mice, Nude Mice, Inbred C57BL Mice, Inbred BALB C Mice, SCID Mice, Transgenic Adenoviridae

Diseases61

Neoplasms Neoplasms, Experimental Breast Neoplasms Neoplasm Metastasis Colonic Neoplasms Ovarian Neoplasms Prostatic Neoplasms Lung Neoplasms Mammary Neoplasms, Experimental Pancreatic Neoplasms Neovascularization, Pathologic Adenocarcinoma Brain Neoplasms Neoplastic Cells, Circulating Neoplasm Invasiveness Stomach Neoplasms Wilms Tumor Cell Transformation, Neoplastic Carcinoma, Ehrlich Tumor Carcinoma, Squamous Cell Disease Progression Liver Neoplasms Fibrosarcoma Carcinoid Tumor Skin Neoplasms Urinary Bladder Neoplasms Neuroendocrine Tumors Kidney Neoplasms Melanoma, Experimental Neoplasm Recurrence, Local Sarcoma, Experimental Bone Neoplasms Glioma Carcinoma, Non-Small-Cell Lung Carcinoma Uterine Cervical Neoplasms Glioblastoma Head and Neck Neoplasms Disease Models, Animal Melanoma Gastrointestinal Neoplasms Colorectal Neoplasms Genetic Predisposition to Disease Rectal Neoplasms Lymphoma Gastrointestinal Stromal Tumors Carcinoma, Hepatocellular Mammary Neoplasms, Animal Esophageal Neoplasms Adenoma Mouth Neoplasms Endometrial Neoplasms Testicular Neoplasms Carcinoma, Small Cell Neuroblastoma Neoplasms, Radiation-Induced Neoplasms, Hormone-Dependent Leydig Cell Tumor Neoplasms, Multiple Primary Thyroid Neoplasms Rhabdoid Tumor

Chemicals and Drugs55

Antineoplastic Agents Antigens, Neoplasm TNF-Related Apoptosis-Inducing Ligand Apoptosis Regulatory Proteins Tumor Markers, Biological Neoplasm Proteins Tumor Necrosis Factor-alpha Antibodies, Monoclonal Tumor Suppressor Protein p53 RNA, Messenger Cancer Vaccines Tumor Suppressor Proteins DNA, Neoplasm Protein Kinase Inhibitors Drugs, Investigational Cisplatin Doxorubicin Enzyme Inhibitors RNA, Small Interfering Pyrimidines Naphthoquinones Drug Carriers Piperazines Angiogenesis Inhibitors RNA, Neoplasm Benzamides Receptors, Estrogen P-Glycoprotein Proto-Oncogene Proteins DNA-Binding Proteins Proto-Oncogene Proteins c-abl Transcription Factors Receptor, erbB-2 Fluorouracil Ki-67 Antigen Carcinogens Antibiotics, Antineoplastic Receptors, Progesterone Paclitaxel Proto-Oncogene Proteins c-bcl-2 Radiation-Sensitizing Agents DNA Primers Membrane Proteins Recombinant Proteins Antineoplastic Agents, Phytogenic Carcinoembryonic Antigen Tamoxifen Proto-Oncogene Proteins c-akt Prostate-Specific Antigen Anticarcinogenic Agents MicroRNAs Antimetabolites, Antineoplastic Radiopharmaceuticals Protein-Serine-Threonine Kinases Antineoplastic Agents, Hormonal

Analytical, Diagnostic and Therapeutic Techniques and Equipment61

Neoplasms, Experimental Oncolytic Virotherapy Genetic Therapy Flow Cytometry Drug Screening Assays, Antitumor Lymphocyte Activation Tumor Burden Xenograft Model Antitumor Assays Drug Discovery Drug Design Molecular Targeted Therapy Drug Delivery Systems Neoplasm Transplantation Mammary Neoplasms, Experimental Early Detection of Cancer Transplantation, Heterologous Blotting, Western Gene Expression Profiling Drug Approval Reverse Transcriptase Polymerase Chain Reaction Clinical Trials as Topic Inhibitory Concentration 50 Neoplasm Staging Models, Biological Transfection Immunohistochemistry Survival Analysis Prognosis Survival Rate Melanoma, Experimental Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Immunotherapy Sarcoma, Experimental Drug Evaluation, Preclinical Retrospective Studies Drug Carriers Polymerase Chain Reaction Immunoenzyme Techniques Tumor Stem Cell Assay Follow-Up Studies Disease Models, Animal Disease-Free Survival Treatment Outcome Oligonucleotide Array Sequence Analysis Sensitivity and Specificity Prospective Studies Kaplan-Meier Estimate Chemotherapy, Adjuvant Gene Knockdown Techniques Risk Tomography, X-Ray Computed Models, Molecular Registries Biopsy Risk Assessment Multivariate Analysis Predictive Value of Tests Reproducibility of Results Positron-Emission Tomography Neoplasm Grading

Phenomena and Processes53

Cytotoxicity, Immunologic Apoptosis Cell Survival Cell Death Drug Resistance, Neoplasm Lymphocyte Activation Gene Expression Regulation, Neoplastic Cell Proliferation Signal Transduction Genes, Tumor Suppressor Cell Division Tumor Microenvironment Dose-Response Relationship, Drug Cell Cycle Time Factors Drug Resistance, Multiple Inhibitory Concentration 50 Mutation Cell Movement Transfection Down-Regulation Cell Growth Processes Base Sequence Up-Regulation Gene Expression Protein Binding Promoter Regions, Genetic Drug Synergism DNA Methylation Genes, p53 Cell Adhesion Phenotype Sensitivity and Specificity Molecular Structure RNA Interference Phosphorylation Genetic Predisposition to Disease Gene Silencing Genetic Vectors Cell Hypoxia Genes, ras Radiation Tolerance Risk Transcription, Genetic Structure-Activity Relationship Loss of Heterozygosity Tissue Distribution Amino Acid Sequence Oncogenes Gene Amplification DNA Damage Protein Structure, Tertiary Enzyme Activation

Disciplines and Occupations4

Drug Discovery Drug Design Medical Oncology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena3

Drug Approval United States Food and Drug Administration National Cancer Institute (U.S.)

Technology, Industry, Agriculture1

Information Science6

Survival Rate Pharmacopoeias as Topic Molecular Sequence Data Base Sequence Amino Acid Sequence Registries

Health Care22

Clinical Trials as Topic Drug Costs Fees, Pharmaceutical Survival Analysis United States Food and Drug Administration Survival Rate Cost Sharing Retrospective Studies Follow-Up Studies Disease-Free Survival Treatment Outcome Sensitivity and Specificity Prospective Studies Kaplan-Meier Estimate Risk National Cancer Institute (U.S.)Registries Risk Assessment Multivariate Analysis Predictive Value of Tests Age Factors Reproducibility of Results

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Health Care Geographicals

Cell Line, Tumor Neoplasms Antineoplastic Agents Cytotoxicity, Immunologic Apoptosis Tumor Cells, Cultured Neoplasms, Experimental Oncolytic Virotherapy Cell Survival Cell Death Antigens, Neoplasm Killer Cells, Natural TNF-Related Apoptosis-Inducing Ligand Genetic Therapy Apoptosis Regulatory Proteins Mice, Nude Flow Cytometry Tumor Markers, Biological T-Lymphocytes, Cytotoxic Mice, Inbred C57BL Drug Resistance, Neoplasm Breast Neoplasms Drug Screening Assays, Antitumor Lymphocyte Activation Gene Expression Regulation, Neoplastic Tumor Burden Cell Proliferation Neoplasm Metastasis Signal Transduction Neoplasm Proteins Xenograft Model Antitumor Assays Mice, Inbred BALB C Drug Discovery Colonic Neoplasms Tumor Necrosis Factor-alpha Drug Design Ovarian Neoplasms Molecular Targeted Therapy Antibodies, Monoclonal Tumor Suppressor Protein p53 Drug Delivery Systems Prostatic Neoplasms Neoplasm Transplantation Lung Neoplasms Mammary Neoplasms, Experimental Genes, Tumor Suppressor Early Detection of Cancer Cell Line Transplantation, Heterologous Cell Division Pancreatic Neoplasms Neovascularization, Pathologic Adenocarcinoma Blotting, Western Brain Neoplasms RNA, Messenger Drug Industry Cancer Vaccines Gene Expression Profiling Tumor Microenvironment Drug Approval Tumor Suppressor Proteins Neoplastic Cells, Circulating Reverse Transcriptase Polymerase Chain Reaction Neoplasm Invasiveness Stomach Neoplasms Clinical Trials as Topic Dose-Response Relationship, Drug DNA, Neoplasm Wilms Tumor Cell Transformation, Neoplastic Cell Cycle Carcinoma, Ehrlich Tumor Carcinoma, Squamous Cell Drug Costs Mice, SCID Disease Progression Time Factors Drug Resistance, Multiple Fees, Pharmaceutical Protein Kinase Inhibitors Inhibitory Concentration 50 Medical Oncology Mutation Drugs, Investigational Liver Neoplasms Neoplasm Staging Cisplatin Fibrosarcoma Macrophages Cell Movement Models, Biological Transfection Carcinoid Tumor Immunohistochemistry Doxorubicin Survival Analysis Skin Neoplasms Urinary Bladder Neoplasms Enzyme Inhibitors

No FAQ available that match "cancer drugs kill tumor cells"